Click for best price
Retinal Disorders Therapy Market Size, Share 2023
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Therapy. This report contains market size and forecasts of Retinal Disorders Therapy in global, including the following market information:
Global Retinal Disorders Therapy Market Revenue, 2018-2023, 20242035, ($ millions)
Global top five companies in 2022 (%)
The global Retinal Disorders Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Age Related Macular Degeneration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Retinal Disorders Therapy include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Disorders Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Disorders Therapy Market, by Type, 2018-2023, 20242035 ($ millions)
Global Retinal Disorders Therapy Market Segment Percentages, by Type, 2022 (%)
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Global Retinal Disorders Therapy Market, by Application, 2018-2023, 20242035 ($ millions)
Global Retinal Disorders Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Retinal Disorders Therapy Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Retinal Disorders Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Disorders Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Retinal Disorders Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Disorders Therapy, market overview.
Chapter 2: Global Retinal Disorders Therapy market size in revenue.
Chapter 3: Detailed analysis of Retinal Disorders Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Disorders Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Retinal Disorders Therapy Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
100 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Disorders Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Disorders Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Disorders Therapy Overall Market Size
2.1 Global Retinal Disorders Therapy Market Size: 2022 VS 2035
2.2 Global Retinal Disorders Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retinal Disorders Therapy Players in Global Market
3.2 Top Global Retinal Disorders Therapy Companies Ranked by Revenue
3.3 Global Retinal Disorders Therapy Revenue by Companies
3.4 Top 3 and Top 5 Retinal Disorders Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Retinal Disorders Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Disorders Therapy Players in Global Market
3.6.1 List of Global Tier 1 Retinal Disorders Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Retinal Disorders Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Disorders Therapy Market Size Markets, 2022 & 2035
4.1.2 Age Related Macular Degeneration
4.1.3 Diabetic Retinopathy
4.1.4 Ocular Inflammatory Disease (Uveitis)
4.1.5 Macular Hole
4.2 By Type - Global Retinal Disorders Therapy Revenue & Forecasts
4.2.1 By Type - Global Retinal Disorders Therapy Revenue, 2018-2023
4.2.2 By Type - Global Retinal Disorders Therapy Revenue, 2024-2035
4.2.3 By Type - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Disorders Therapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Retinal Disorders Therapy Revenue & Forecasts
5.2.1 By Application - Global Retinal Disorders Therapy Revenue, 2018-2023
5.2.2 By Application - Global Retinal Disorders Therapy Revenue, 2024-2035
5.2.3 By Application - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Retinal Disorders Therapy Market Size, 2022 & 2035
6.2 By Region - Global Retinal Disorders Therapy Revenue & Forecasts
6.2.1 By Region - Global Retinal Disorders Therapy Revenue, 2018-2023
6.2.2 By Region - Global Retinal Disorders Therapy Revenue, 2024-2035
6.2.3 By Region - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Retinal Disorders Therapy Revenue, 2018-2035
6.3.2 US Retinal Disorders Therapy Market Size, 2018-2035
6.3.3 Canada Retinal Disorders Therapy Market Size, 2018-2035
6.3.4 Mexico Retinal Disorders Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Retinal Disorders Therapy Revenue, 2018-2035
6.4.2 Germany Retinal Disorders Therapy Market Size, 2018-2035
6.4.3 France Retinal Disorders Therapy Market Size, 2018-2035
6.4.4 U.K. Retinal Disorders Therapy Market Size, 2018-2035
6.4.5 Italy Retinal Disorders Therapy Market Size, 2018-2035
6.4.6 Russia Retinal Disorders Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Retinal Disorders Therapy Market Size, 2018-2035
6.4.8 Benelux Retinal Disorders Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Retinal Disorders Therapy Revenue, 2018-2035
6.5.2 China Retinal Disorders Therapy Market Size, 2018-2035
6.5.3 Japan Retinal Disorders Therapy Market Size, 2018-2035
6.5.4 South Korea Retinal Disorders Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Retinal Disorders Therapy Market Size, 2018-2035
6.5.6 India Retinal Disorders Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Retinal Disorders Therapy Revenue, 2018-2035
6.6.2 Brazil Retinal Disorders Therapy Market Size, 2018-2035
6.6.3 Argentina Retinal Disorders Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retinal Disorders Therapy Revenue, 2018-2035
6.7.2 Turkey Retinal Disorders Therapy Market Size, 2018-2035
6.7.3 Israel Retinal Disorders Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Retinal Disorders Therapy Market Size, 2018-2035
6.7.5 UAE Retinal Disorders Therapy Market Size, 2018-2035
7 Retinal Disorders Therapy Companies Profiles
7.1 ALLERGAN
7.1.1 ALLERGAN Company Summary
7.1.2 ALLERGAN Business Overview
7.1.3 ALLERGAN Retinal Disorders Therapy Major Product Offerings
7.1.4 ALLERGAN Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.1.5 ALLERGAN Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Company Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Retinal Disorders Therapy Major Product Offerings
7.2.4 AbbVie Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.2.5 AbbVie Key News & Latest Developments
7.3 Alimera Sciences
7.3.1 Alimera Sciences Company Summary
7.3.2 Alimera Sciences Business Overview
7.3.3 Alimera Sciences Retinal Disorders Therapy Major Product Offerings
7.3.4 Alimera Sciences Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.3.5 Alimera Sciences Key News & Latest Developments
7.4 Janssen Biotech
7.4.1 Janssen Biotech Company Summary
7.4.2 Janssen Biotech Business Overview
7.4.3 Janssen Biotech Retinal Disorders Therapy Major Product Offerings
7.4.4 Janssen Biotech Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.4.5 Janssen Biotech Key News & Latest Developments
7.5 Swedish Orphan Biovitrum
7.5.1 Swedish Orphan Biovitrum Company Summary
7.5.2 Swedish Orphan Biovitrum Business Overview
7.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Major Product Offerings
7.5.4 Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.5.5 Swedish Orphan Biovitrum Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Retinal Disorders Therapy Major Product Offerings
7.6.4 Roche Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Major Product Offerings
7.7.4 Bristol-Myers Squibb Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Genzyme
7.8.1 Genzyme Company Summary
7.8.2 Genzyme Business Overview
7.8.3 Genzyme Retinal Disorders Therapy Major Product Offerings
7.8.4 Genzyme Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.8.5 Genzyme Key News & Latest Developments
7.9 Genentech
7.9.1 Genentech Company Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Retinal Disorders Therapy Major Product Offerings
7.9.4 Genentech Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.9.5 Genentech Key News & Latest Developments
7.10 OCULAR THERAPEUTIX
7.10.1 OCULAR THERAPEUTIX Company Summary
7.10.2 OCULAR THERAPEUTIX Business Overview
7.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Major Product Offerings
7.10.4 OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.10.5 OCULAR THERAPEUTIX Key News & Latest Developments
7.11 Bausch & Lomb
7.11.1 Bausch & Lomb Company Summary
7.11.2 Bausch & Lomb Business Overview
7.11.3 Bausch & Lomb Retinal Disorders Therapy Major Product Offerings
7.11.4 Bausch & Lomb Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.11.5 Bausch & Lomb Key News & Latest Developments
7.12 UCBCares
7.12.1 UCBCares Company Summary
7.12.2 UCBCares Business Overview
7.12.3 UCBCares Retinal Disorders Therapy Major Product Offerings
7.12.4 UCBCares Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.12.5 UCBCares Key News & Latest Developments
7.13 Aier Eye Hospital
7.13.1 Aier Eye Hospital Company Summary
7.13.2 Aier Eye Hospital Business Overview
7.13.3 Aier Eye Hospital Retinal Disorders Therapy Major Product Offerings
7.13.4 Aier Eye Hospital Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.13.5 Aier Eye Hospital Key News & Latest Developments
7.14 Alcon Holdings, Inc.
7.14.1 Alcon Holdings, Inc. Company Summary
7.14.2 Alcon Holdings, Inc. Business Overview
7.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Major Product Offerings
7.14.4 Alcon Holdings, Inc. Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.14.5 Alcon Holdings, Inc. Key News & Latest Developments
7.15 Eyebright Medical
7.15.1 Eyebright Medical Company Summary
7.15.2 Eyebright Medical Business Overview
7.15.3 Eyebright Medical Retinal Disorders Therapy Major Product Offerings
7.15.4 Eyebright Medical Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.15.5 Eyebright Medical Key News & Latest Developments
7.16 Kanghong Pharmaceutical
7.16.1 Kanghong Pharmaceutical Company Summary
7.16.2 Kanghong Pharmaceutical Business Overview
7.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Major Product Offerings
7.16.4 Kanghong Pharmaceutical Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.16.5 Kanghong Pharmaceutical Key News & Latest Developments
7.17 Huaxia Eye Hospital
7.17.1 Huaxia Eye Hospital Company Summary
7.17.2 Huaxia Eye Hospital Business Overview
7.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Major Product Offerings
7.17.4 Huaxia Eye Hospital Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.17.5 Huaxia Eye Hospital Key News & Latest Developments
7.18 Xingqi Pharmaceutical
7.18.1 Xingqi Pharmaceutical Company Summary
7.18.2 Xingqi Pharmaceutical Business Overview
7.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Major Product Offerings
7.18.4 Xingqi Pharmaceutical Retinal Disorders Therapy Revenue in Global Market (2018-2023)
7.18.5 Xingqi Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Retinal Disorders Therapy Market Opportunities & Trends in Global Market
Table 2. Retinal Disorders Therapy Market Drivers in Global Market
Table 3. Retinal Disorders Therapy Market Restraints in Global Market
Table 4. Key Players of Retinal Disorders Therapy in Global Market
Table 5. Top Retinal Disorders Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Retinal Disorders Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Retinal Disorders Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Retinal Disorders Therapy Product Type
Table 9. List of Global Tier 1 Retinal Disorders Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Disorders Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Retinal Disorders Therapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Retinal Disorders Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Retinal Disorders Therapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Retinal Disorders Therapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Retinal Disorders Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Retinal Disorders Therapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Retinal Disorders Therapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Retinal Disorders Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Retinal Disorders Therapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Retinal Disorders Therapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Retinal Disorders Therapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Retinal Disorders Therapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Retinal Disorders Therapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Retinal Disorders Therapy Revenue, (US$, Mn), 2024-2035
Table 30. ALLERGAN Company Summary
Table 31. ALLERGAN Retinal Disorders Therapy Product Offerings
Table 32. ALLERGAN Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. ALLERGAN Key News & Latest Developments
Table 34. AbbVie Company Summary
Table 35. AbbVie Retinal Disorders Therapy Product Offerings
Table 36. AbbVie Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. AbbVie Key News & Latest Developments
Table 38. Alimera Sciences Company Summary
Table 39. Alimera Sciences Retinal Disorders Therapy Product Offerings
Table 40. Alimera Sciences Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Alimera Sciences Key News & Latest Developments
Table 42. Janssen Biotech Company Summary
Table 43. Janssen Biotech Retinal Disorders Therapy Product Offerings
Table 44. Janssen Biotech Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Janssen Biotech Key News & Latest Developments
Table 46. Swedish Orphan Biovitrum Company Summary
Table 47. Swedish Orphan Biovitrum Retinal Disorders Therapy Product Offerings
Table 48. Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Swedish Orphan Biovitrum Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Retinal Disorders Therapy Product Offerings
Table 52. Roche Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Retinal Disorders Therapy Product Offerings
Table 56. Bristol-Myers Squibb Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Genzyme Company Summary
Table 59. Genzyme Retinal Disorders Therapy Product Offerings
Table 60. Genzyme Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Genzyme Key News & Latest Developments
Table 62. Genentech Company Summary
Table 63. Genentech Retinal Disorders Therapy Product Offerings
Table 64. Genentech Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Genentech Key News & Latest Developments
Table 66. OCULAR THERAPEUTIX Company Summary
Table 67. OCULAR THERAPEUTIX Retinal Disorders Therapy Product Offerings
Table 68. OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. OCULAR THERAPEUTIX Key News & Latest Developments
Table 70. Bausch & Lomb Company Summary
Table 71. Bausch & Lomb Retinal Disorders Therapy Product Offerings
Table 72. Bausch & Lomb Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Bausch & Lomb Key News & Latest Developments
Table 74. UCBCares Company Summary
Table 75. UCBCares Retinal Disorders Therapy Product Offerings
Table 76. UCBCares Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. UCBCares Key News & Latest Developments
Table 78. Aier Eye Hospital Company Summary
Table 79. Aier Eye Hospital Retinal Disorders Therapy Product Offerings
Table 80. Aier Eye Hospital Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Aier Eye Hospital Key News & Latest Developments
Table 82. Alcon Holdings, Inc. Company Summary
Table 83. Alcon Holdings, Inc. Retinal Disorders Therapy Product Offerings
Table 84. Alcon Holdings, Inc. Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Alcon Holdings, Inc. Key News & Latest Developments
Table 86. Eyebright Medical Company Summary
Table 87. Eyebright Medical Retinal Disorders Therapy Product Offerings
Table 88. Eyebright Medical Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Eyebright Medical Key News & Latest Developments
Table 90. Kanghong Pharmaceutical Company Summary
Table 91. Kanghong Pharmaceutical Retinal Disorders Therapy Product Offerings
Table 92. Kanghong Pharmaceutical Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Kanghong Pharmaceutical Key News & Latest Developments
Table 94. Huaxia Eye Hospital Company Summary
Table 95. Huaxia Eye Hospital Retinal Disorders Therapy Product Offerings
Table 96. Huaxia Eye Hospital Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Huaxia Eye Hospital Key News & Latest Developments
Table 98. Xingqi Pharmaceutical Company Summary
Table 99. Xingqi Pharmaceutical Retinal Disorders Therapy Product Offerings
Table 100. Xingqi Pharmaceutical Retinal Disorders Therapy Revenue (US$, Mn) & (2018-2023)
Table 101. Xingqi Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Retinal Disorders Therapy Segment by Type in 2022
Figure 2. Retinal Disorders Therapy Segment by Application in 2022
Figure 3. Global Retinal Disorders Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Retinal Disorders Therapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Retinal Disorders Therapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Disorders Therapy Revenue in 2022
Figure 8. By Type - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Retinal Disorders Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Retinal Disorders Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 16. US Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 20. Germany Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 28. China Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 34. Brazil Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Retinal Disorders Therapy Revenue Market Share, 2018-2035
Figure 37. Turkey Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Retinal Disorders Therapy Revenue, (US$, Mn), 2018-2035
Figure 41. ALLERGAN Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AbbVie Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Alimera Sciences Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Janssen Biotech Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-Myers Squibb Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genzyme Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Genentech Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bausch & Lomb Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. UCBCares Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Aier Eye Hospital Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Alcon Holdings, Inc. Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Eyebright Medical Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Kanghong Pharmaceutical Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Huaxia Eye Hospital Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Xingqi Pharmaceutical Retinal Disorders Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
